A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
NCT01493726
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
ALKS 9072, Low dose
DRUG:
ALKS 9072, Med dose
DRUG:
ALKS 9072, High dose
DRUG:
Placebo
Sponsor
Alkermes, Inc.